Showing results (321-330 of 372) with videos related to

Sort By:
Pageof 38
American Journal of Clinical Oncology|October 7, 2003
Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003Paul Okunieff, Raymond E Meyn, Beverly A Teicher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell supportA D Elias, C Wheeler, L J Ayash, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignanciesT S Herman, M S Jochelson, B A Teicher, et al.
Molecular Cancer Therapeutics|August 30, 2008
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248Rebecca G Bagley, Cecile Rouleau, Thia St Martin, et al.
International Journal of Oncology|March 25, 2008
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contributionCecile Rouleau, Krishna Menon, Paula Boutin, et al.
Molecular Cancer Therapeutics|January 22, 2011
sFLT01: a novel fusion protein with antiangiogenic activityRebecca G Bagley, Leslie Kurtzberg, William Weber, et al.
Cancer Research Communications|September 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer TypesZahra Davoudi, Thomas S Dexheimer, Nathan P Coussens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung CancerBenjamin H Lok, Eric E Gardner, Valentina E Schneeberger, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2019
Exposure time versus cytotoxicity for anticancer agentsDavid M Evans, Jianwen Fang, Thomas Silvers, et al.
Molecular Cancer Therapeutics|July 5, 2018
Inhibition of Parp1 by BMN673 Effectively Sensitizes Cells to Radiotherapy by Upsetting the Balance of Repair Pathways Processing DNA Double-Strand BreaksAashish Soni, Fanghua Li, You Wang, et al.
Pageof 38